Targeting of hematopoietic progenitor cells with MR contrast agents

Radiology

Volumn 228, Issue 3, 2003, Pages 760-767

  Daldrup Link, Heike E ^a   Rudelius, Martina ^a   Oostendorp, Robert A J ^a   Settles, Marcus ^a   Piontek, Guido ^a   Metz, Stefan ^a   Rosenbrock, Hilkea ^a   Keller, Ulrich ^a   Heinzmann, Ulrich ^a   Rummeny, Ernst J ^a   Schlegel, Jürgen ^a   Link, Thomas M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Experimental study; Iron; Magnetic resonance (MR), contrast media; Magnetic resonance (MR), experimental studies; Molecular analysis; Stem cells

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE MEGLUMINE; LIPOSOME; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE; TRANSFERRIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CELL DIFFERENTIATION; CELL SUSPENSION; CELL VIABILITY; DRUG EFFECT; ELECTRON MICROSCOPY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPECTROMETRY; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TARGET CELL;

CELL SURVIVAL; CONTRAST MEDIA; FERRIC COMPOUNDS; GADOLINIUM DTPA; HEMATOPOIETIC STEM CELLS; HUMANS; IRON; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MICROSCOPY, ELECTRON; OXIDES; SPECTROPHOTOMETRY; SPECTROPHOTOMETRY, ATOMIC; TRANSFERRIN;

EID: 0041930579     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2283020322     Document Type: Article

References (29)

1. Molina A, Popplewell L, Kashyap A, Nademanee A. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Ann N Y Acad Sci 2001; 938: 54-61.
2. Lewin M, Carlesso N, Tung CH, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000; 18:410-414.
3. Weissleder R, Cheng H, Bogdanova A, Bogdanov A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997; 7:258-263.
4. Högemann D, Josephson L, Weissleder R, Basilion J. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjugate Chem 2000; 11:941-946.
5. Yeh T, Zhang W, Ildstad S, Ho C. In vivo dynamic MRI tracking of rat T-cells labeled with superparamagnetic iron oxide particles. Magn Reson Med 1995; 33:200-208.
6. Schoepf U, Marecos E, Melder R, Jain R, Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998; 24:642-651.
7. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele H, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
8. Weissleder R. Liver MR imaging with iron oxides: toward consensus and clinical practice. Radiology 1994; 193:593-595.
9. Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995; 13:675-691.
10. Chambon C, Clement O, Le Blanche A, Schouman-Claeys E, Frija G. Superparamagnetic iron oxides as positive contrast agents: in vitro and in vivo evidence. Magn Reson Imaging 1993; 11:509-519.
11. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989; 152:167-173.
12. Weinmann H, Brasch R, Press W, Wesbey G. Characteristics of gadolinium-DTPA complex: a potential new NMR contrast agent. AJR Am J Roentgenol 1984; 142: 619-624.
13. Weinmann H, Laniado M, Mützel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984; 16:167-172.
14. Felgner P, Gadek T, Holm M, et al. Lipofectin: a highly efficient, lipid mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987; 84:7413-7417.
15. Daldrup-Link HE, Rummeny EJ, Ihssen B, Kienast J, Link TM. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002; 12:1557-1566.
16. Wolff S, Balaban R. Assessing contrast on MR images. Radiology 1997; 202:25-29.
17. In den Kleef JJE, Cuppen JJM. RLSQ: T1, T2 and rho calculations, combining ratios and least squares. Magn Reson Med 1987; 5:513-524.
18. Gillis P, Moiny F, Brooks RA. On T2-shortening by strongly magnetized spheres: a partial refocusing model. Magn Reson Med 2002; 47:257-263.
19. Bulte J, Douglas T, Witwer B, et al. Magnetodendrimers allow endosomal and in vivo tracking of stem cells. Nat Biotechnol 2001; 19:1141-1147.
20. Josephson L, Tung CH, Moore A, Weissleder R. High-efficiency intracellular magnetic labeling with novel super-paramagnetic-tat peptide conjugates. Bioconjugate Chem 1999; 10:186-191.
21. Bogdanov A, Weissleder R. The development of in vivo imaging systems to study gene expression. Trends Biotechnol 1998; 16:5-10.
22. Felgner P, Ringold G. Cationic liposome-mediated transfection. Nature 1989; 337: 387-388.
23. Lasic D, Papahadjopoulos D. Liposomes revisited. Science 1995; 267:1275-1276.
24. Felgner P, Tsai Y, Sukhu L, et al. Improved cationic lipid formulations for in vivo gene therapy. Ann N Y Acad Sci 1995; 772:126-139.
25. Boerman O, Storm G, Oyen W. Sterically stabilized liposomes labeled with indium-11 to image focal infection. J Nucl Med 1995; 36:1639-1644.
26. Kresse M, Wagner S, Pfefferer D, Lawaczeck R, Elste V, Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med 1998; 40:236-242.
27. Fawwaz R, Oluwole T, Wang N, et al. Biodistribution of radiolabeled lymphocytes. Radiology 1985; 155:483-486.
28. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701-704.
29. Melder R, Brownell A, Shoup T, Brownell G, Jain R. Imaging of natural killer cells in mice by positron emission tomography: preferential uptake in tumors. Cancer Res 1993; 53:5867-5871.